Fig. 2From: Application of a framework to guide genetic testing communication across clinical indicationsCADRe communication rubrics. a Pre-test discussion rubric. b Post-test discussion rubric. P/LP, pathogenic/likely pathogenic results that are indicative of a molecular diagnosis and/or risk; B/LB, benign/likely benign; VUS/GUS, variant of uncertain significance/gene of uncertain significanceBack to article page